The country which mass produces the vaccine

As the nations and the scientists work around the clock to develop a potential Corona vaccine. The main challenge lies after the development, the mass production of the vaccine. So now iam gonna talk about the companies and countries which fill this need.

(Vaccine Manufacturing. Image Credit: The Serum Institute of India) 

Note : Iam not a government official or any member of Vaccine reaserch or distribution. Nor an expert in vaccine trials or distribution. Iam just a medical student from India who's just here to share my views.

As per 2019 data Here are the top 10 companies operating global Vaccines Market :

1. Sanofi Pasteur:

Incorporated in 1994 and headquartered at Paris, France, Sanofi is one of the leading players in the pharmaceuticals market. The company is engaged in the research, development, manufacture, and marketing of therapeutic solutions. The company operates through three segments, namely, pharmaceuticals, consumer health, and vaccines via Sanofi Pasteur. The company sells vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.

Sanofi Pasteur SA operates in about 150 countries. Annually, more than 500 million people around the world receive company vaccines and the unit provides more than 1 billion vaccine doses.

2. Merck & Co. Inc,

Founded in 1891 and headquartered at New Jersey, U.S.; Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company engaged in the discovery, development, manufacturing and selling of pharmaceuticals and vaccines for human and animal healthcare markets. The Pharmaceutical segment of the company includes human health pharmaceutical and vaccine products.

The company has a strong footprint across the globe. Outside the US, the company has its major operations in Europe, Japan, Asia-Pacific, and Latin America.

3. GlaxoSmithKline plc (GSK)

Founded 2000 and headquartered at Brentford, UK; GlaxoSmithKline plc (GSK) is a pharmaceutical, biological, and healthcare company engaged in the development, manufacture, and marketing of pharmaceutical and consumer health-related products. GSK operates through three industry segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. Through its vaccine segment, the company is focused to bring differentiated, high-quality, and needed vaccines. Currently, the company has more than 10 vaccines in pipeline.

The company operates in almost 120 countries and its products are sold in over 150 countries worldwide. The company is headquartered in Middlesex, in the U.K.

Note: The capacity of mass producing a vaccine is not only the criteria but the vaccine should be affordable this is where the Indian drug manufacturers come in. 

India is the pharmacy of the world. It produces highest number of vaccines in the world and that too at a low cost.

India is among the largest manufacturer of generic drugs and vaccines in the world. It is home to half a dozen major vaccine makers and a host of smaller ones, making doses against polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps and rubella, among other diseases.

Now half a dozen Indian firms are developing vaccines against the virus that causes Covid-19.

Serum Institute of India(SII) 

                    (A clip from SII website) 

Serum Institute of India, the world's largest vaccine maker by number of doses produced and sold globally. The 53-year-old company makes 1.5 billion doses every year, mainly from its two facilities in the western city of Pune. (It has two other small plants in the Netherlands and the Czech Republic.) Around 7,000 people work for the firm.

The company supplies some 20 vaccines to 165 countries. Some 80% of its vaccines are exported and, at an average of 50 cents a dose, they are some of the cheapest in the world.

Now the firm has stitched up collaboration with Codagenix, an American biotech company, to develop a "live attenuated" vaccine, among the more than 80 reportedly in development all over the world. 

This is where Indian vaccine makers have a head start over others. Mr Poonawalla's firm alone has an extra capacity of 400 to 500 million doses. "We have lots of capacity as we have invested in it," he says.

There's more. Hyderabad-based Bharat Biotech had announced a partnership with the University of Wisconsin Madison and US-based firm FluGen to make almost 300 million doses of a vaccine for global distribution. Zydus Cadilla is working on two vaccines, while Biological E, Indian Immunologicals, and Mynvax are developing a vaccine each. Another four or five home-grown vaccines are in early stages of development. 

As a conclusion which ever the country may develop a vaccine India is gonna play a crucial role. So as a trade of Indians gonna get Vaccine earlier.

For personal enquires or for sharing the ideas or correcting me for any mistakes. 

you can send a email to Yashwantht50@gmail.com

Please support me so I can get more interesting content for you.